JPWO2021021606A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021021606A5
JPWO2021021606A5 JP2022505282A JP2022505282A JPWO2021021606A5 JP WO2021021606 A5 JPWO2021021606 A5 JP WO2021021606A5 JP 2022505282 A JP2022505282 A JP 2022505282A JP 2022505282 A JP2022505282 A JP 2022505282A JP WO2021021606 A5 JPWO2021021606 A5 JP WO2021021606A5
Authority
JP
Japan
Prior art keywords
fusion protein
variant
item
composition
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022505282A
Other languages
English (en)
Japanese (ja)
Other versions
JP7483857B2 (ja
JP2022541657A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/043416 external-priority patent/WO2021021606A1/en
Publication of JP2022541657A publication Critical patent/JP2022541657A/ja
Publication of JPWO2021021606A5 publication Critical patent/JPWO2021021606A5/ja
Application granted granted Critical
Publication of JP7483857B2 publication Critical patent/JP7483857B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022505282A 2019-07-26 2020-07-24 インターロイキン－２作用物質およびその使用 Active JP7483857B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962879137P 2019-07-26 2019-07-26
US62/879,137 2019-07-26
US202062983061P 2020-02-28 2020-02-28
US62/983,061 2020-02-28
PCT/US2020/043416 WO2021021606A1 (en) 2019-07-26 2020-07-24 Interleukin-2 agents and uses thereof

Publications (3)

Publication Number Publication Date
JP2022541657A JP2022541657A (ja) 2022-09-26
JPWO2021021606A5 true JPWO2021021606A5 (ru) 2023-11-16
JP7483857B2 JP7483857B2 (ja) 2024-05-15

Family

ID=

Similar Documents

Publication Publication Date Title
JP7087047B2 (ja) 改変されたインターロイキン－７タンパク質およびその使用
TWI223663B (en) IL-2 selective agonists and antagonists
TWI257394B (en) Thrombopoietic compounds
US20240059751A1 (en) Interleukin-2 variants and methods of uses thereof
TWI488864B (zh) 用於治療癌症及慢性感染之具有促效劑活性之介白素－２（ｉｌ－２）衍生物多肽
TW496870B (en) Compositions methods for stimulating megakaryocyte growth and differentiation
ES2329334T3 (es) Formas multimericas de ligandos de la superfamilia de tnf.
ES2210255T3 (es) Metodos para mejorar la actividad biologica de quimiocinas.
CA2993891A1 (en) Interleukin-15 fusion proteins for tumor targeting therapy
US20190216898A1 (en) Interleukin Combination and Use Thereof
JP2017529059A5 (ru)
RU2010122053A (ru) Иммуносупрессорные полипептиды и нуклеиновые кислоты
CN101675071A (zh) 经修饰干扰素β多肽和其用途
EP2343081A1 (en) Interferon analogs
TW200938632A (en) Recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo and pharmaceutical composition containing the same
CA3143038A1 (en) Novel interleukin-2 variants and bifunctional fusion molecules thereof
SK287523B6 (sk) Použitie CC chemokínového mutanta, farmaceutický prostriedok s obsahom chemokínového mutanta, skrátený a mutovaný humánny RANTES a spôsob jeho výroby
WO2008152508A2 (en) Cytokine conjugate
JPH04505019A (ja) ガンマインターフェロンのポリペプチド性阻害剤
WO2019146673A1 (ja) リンパ球の製造方法
TWI785426B (zh) 包含含有il-2蛋白及cd80蛋白之融合蛋白與自然殺手細胞的用於治療癌症的藥學組成物
JPWO2021021606A5 (ru)
US20220242946A1 (en) Methods and materials for targeted expansion of regulatory t cells
KR20220029477A (ko) IL15 단백질, IL15 수용체 알파 단백질, Fc 도메인 및 IL2 단백질을 포함하는 융합단백질 및 이의 용도
WO2021199046A9 (en) Immunomodulatory compositions and use thereof